BioAge Labs (BIOA) Balance Sheet: Assets & Liabilities

BioAge Labs (BIOA) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), BioAge Labs reported total assets of $294.89M and total liabilities of $22.84M. Shareholders' equity was $272.05M, down 15.8% from $323.13M a year earlier. Total debt stood at $5.56M against $281.10M in cash and short-term investments, a net cash position of $275.54M. That puts debt-to-equity at 0.02, compared with 0.03 a year earlier.

BioAge Labs Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for BioAge Labs, Inc. (BIOA) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022
Current Assets
Cash and Cash Equivalents	188.89	354.35	21.64	27.64
Short-Term Investments	92.21	0.00	0.00	0.00
Cash & Short-Term Investments	281.10	354.35	21.64	27.64
Accounts Receivable	0.77	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00
Other Current Assets	4.93	2.75	0.35	0.39
Total Current Assets	286.79	357.10	25.31	28.03
Non-Current Assets
Property, Plant & Equipment (Net)	3.75	0.79	0.52	0.37
Long-Term Investments	0.10	0.10	0.10	0.00
Other Non-Current Assets	4.25	0.24	0.00	0.03
Total Non-Current Assets	8.10	1.13	0.62	0.40
Total Assets	294.89	358.23	25.92	28.43
Current Liabilities
Accounts Payable	2.67	2.00	1.87	2.26
Short-Term Debt	3.23	6.00	20.67	0.17
Current Portion of Long-Term Debt	2.65	6.00	6.00	0.17
Accrued Liabilities	8.48	11.33	7.94	3.38
Deferred Revenue	5.75	7.83	3.31	0.00
Other Current Liabilities	8.48	0.42	18.18	0.02
Total Current Liabilities	20.14	27.78	58.17	5.86
Non-Current Liabilities
Long-Term Debt	2.33	2.50	8.20	2.25
Other Non-Current Liabilities	0.37	4.83	0.23	0.15
Total Non-Current Liabilities	2.70	7.33	8.43	2.41
Total Liabilities	22.84	35.11	66.60	8.27
Stockholders' Equity
Retained Earnings	-333.42	-252.81	-181.70	-117.85
Accumulated Other Comprehensive Income	0.28	0.25	0.16	0.17
Additional Paid-in Capital	605.19	575.69	8.14	5.12
Shares Outstanding	37.39	35.85	34.17	34.17
Total Stockholders' Equity	272.05	323.13	-40.67	20.16
Total Liabilities & Equity	294.89	358.23	25.92	28.43

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About BioAge Labs Balance Sheet

How much debt does BioAge Labs have?

BioAge Labs had total debt of $5.56M as of Dec 31, 2025, against $281.10M in cash and short-term investments. Its debt-to-equity ratio was 0.02. Total debt was $8.50M a year earlier.

What are BioAge Labs's total assets?

BioAge Labs reported total assets of $294.89M as of Dec 31, 2025, down 17.7% from $358.23M a year earlier. Total liabilities were $22.84M.

What is BioAge Labs's shareholders' equity?

BioAge Labs's shareholders' equity was $272.05M as of Dec 31, 2025, or about $7.28 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition